Fear of moving holds back RA patients more than disease itself?
NCT ID NCT07435272
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how fear of movement (kinesiophobia) affects daily function in people with rheumatoid arthritis. Researchers will compare 200 RA patients with 200 healthy volunteers to understand links between fear, pain, fatigue, mood, and muscle loss. The goal is to find non-inflammatory factors that limit mobility and guide better rehabilitation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 400 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Mar 2026
An estimate. Start dates often move.
- Expected to finish
-
Oct 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Two hundred adult patients previously diagnosed with RA according to ACR/EULAR 2010 criteria for RA and 200 apparently healthy volunteers with age and sex matching will be involved in the study. All patients included in this study will be verbally briefed about the details and the nature of the study \& will sign a written informed consent according to the local Ethics Committee of Minia University Faculty of Medicine. The study will be conducted in Rheumatology department, Minia university Hospital, Egypt.
- Ages
-
18 to 69 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age: adult population with RA (18-69) * Disease duration ≥ 6 months Exclusion Criteria: 1. Juvenile cases 2. Other rheumatic diseases (SLE, AS, 1ry OA, etc.) 3. Trauma 4. Comorbidities that affect mobility, e.g., UMNL (including stroke), parkinsonism, multiple sclerosis, cerebral palsy, dementia, peripheral neuropathy, chronic pain conditions, etc. 5. Previous history of psychiatric illness before onset of RA (anxiety, depression, etc.) 6. Pregnancy and lactation
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Kinesiophobia (fear of movement) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Smartphone app aims to catch rheumatoid arthritis before it takes hold
- Could a simple wrist injection silence arthritis pain?
- A patient questionnaire may rival lab tests for spotting rheumatoid arthritis flares
- Could fewer pills mean same relief for rheumatoid arthritis?
- Can a single cell therapy calm multiple autoimmune diseases?
- Heart risk in rheumatoid arthritis: could a blood vessel drug help?